Chief Revenue Officer, Viz
$250-287.5k
+ Executive bonus + Options
AI-powered care coordination
Be an early applicant
AI-powered care coordination
201-500 employees
Be an early applicant
$250-287.5k
+ Executive bonus + Options
201-500 employees
Company mission
To make healthcare work faster and smarter.
Role
Who you are
- 15+ years of healthcare technology sales leadership, including 5+ years at VP or CRO level leading enterprise provider sales
- Proven success closing complex SaaS or workflow deals with provider C-Suites (especially CMOs and other Clinical Executives)
- Experience scaling from departmental to enterprise-wide adoption across hospitals and IDNs
- Background in AI, SaaS, EHR, revenue cycle management, or ambient listening solutions
- Strong command of pricing models that scale, pipeline management, and forecasting accuracy
- A builder and coach, with a track record of developing high-performing commercial teams in high-growth environments
- Collaborative, cross-functional leader who thrives on alignment with Marketing, Product, Finance, and Customer Success
- Mission-driven, passionate about improving healthcare through AI innovation
- AI Native: You leverage AI tools (e.g., ChatGPT) as part of your workflow to enhance productivity and output
What the job involves
- We are seeking a proven commercial leader to join Viz.ai as our Chief Revenue Officer (CRO)
- Reporting directly to the CEO, the CRO will own the provider revenue number and lead the commercial engine—including Provider Sales, Customer Success, Sales Operations, and Deal Execution
- This highly strategic, hands-on leader will shape and execute Viz.ai’s go-to-market strategy, expand our enterprise footprint, and ensure that every customer realizes measurable value from our solutions
- The CRO will be a trusted partner to health system executives, particularly CMOs and CFOs, and will play a key role in advancing Viz.ai’s mission of improving healthcare delivery through AI
- Own & Grow Revenue: Drive predictable growth by leveraging Viz.ai’s large footprint across hospitals, health systems, and large IDNs to grow sales
- Enterprise Sales Leadership: Personally engage with C-Suite executives (clinical and financial) to win complex, multi-stakeholder enterprise deals
- Build & Scale Teams: Lead, mentor, and expand a high-performing provider sales organization; ensure world-class productivity and execution
- Go-to-Market Strategy: Define and evolve Viz.ai’s commercial approach across strategic, regional, and enterprise accounts
- Customer Success: Scale post-sales to drive retention, expansion, and customer advocacy
- Operational Excellence: Establish best-in-class pipeline management, forecasting, and sales enablement practices
- Market Expansion: Identify and capture new opportunities across adjacent workflows, health systems, and IDNs
- Industry Leadership: Represent Viz as a thought leader in digital health and AI-enabled care transformation externally with customers, partners, and at industry forums
Our take
In the U.S, strokes are the third leading cause of death killing more than 140,000 people annually. These fatality rates are partially a result of strokes being hard to diagnose, and once they occur it is often too late.
Viz uses artificial intelligence to rapidly identify stroke victims to provide treatment faster, aiming to save lives and the financial costs associated with medical treatment. The company achieves this by using machine learning which is trained to identify anomalies within brain scans that neuroscientists struggle to spot.
With a valuation of over $1 billion, in 2023, Viz secured capital from pharmaceutical giant Bristol-Meyers-Squibbs to develop an AI algorithm and provider workflow focused on detecting hypertrophic cardiomyopathy. This is part of Viz's objective of branching out from a focus on strokes into new healthcare territory, such as through its 2025 partnership with precision oncology company Guardant Health to combat lung cancer.
Kirsty
Company Specialist at Welcome to the Jungle
Insights
5% employee growth in 12 months
Company
Funding (last 2 of 8 rounds)
Mar 2023
$40m
GROWTH EQUITY VC
Apr 2022
$100m
SERIES D
Total funding: $292.1m
Company benefits
- Work from home opportunities
Company HQ
SoMa, San Francisco, CA
Leadership
Dr Chris Mansi
(CEO)Was a Neurosurgeon for 4 years before co-founding EDUSURG, an online medical education platform for surgeons, where they also served as CEO.
David Golan
(CTO)Was an algorithm developer at b-hive networks and VMware, before becoming a Teaching Assistant at Tel Aviv University. Was also a Postdoctoral Fellow at Stanford.
Share this job
View 4 more jobs at Viz